Clinical Trial Update: [18F]-AraG PET Imaging in LA HNSCC [EARLY_Phase 1]

View source ↗

Summary

This is an early-phase study evaluating [18F]-AraG PET imaging in locally advanced head and neck squamous cell carcinoma, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• [18F]-AraG PET imaging tracer (18F-AraG radiotracer)

Snippet

Sponsor: Indiana University | Conditions: Head and Neck Squamous Cell Carcinoma (HNSCC), Locally Advanced Head and Neck Squamous Cell Carcinoma | EARLY_Phase 1 | Status: NOT_YET_RECRUITING